SCHEMBL8093429

SCHEMBL8093429

CN(C)NC(=O)COc1nc(-c2ccc(F)cc2)c(-c2ccc(S(N)(=O)=O)cc2)cc1C#N

nearest known ligand 0.44

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 8/20 0.44
PTGS2 P35354 4/20 0.42
PTGS1 P23219 3/20 0.42
CA12 O43570 4/20 0.41
CA1 P00915 4/20 0.41
CA2 P00918 4/20 0.41
CA9 Q16790 4/20 0.41
CDK1 P06493 1/20 0.40
KDR P35968 1/20 0.40
CHUK O15111 2/20 0.39
ALDH1A1 P00352 1/20 0.39
LMNA P02545 1/20 0.39
IKBKB O14920 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8093983 0.87 CNR1 (0.44) CNR1PTGS2PTGS1CA12CA1
SCHEMBL8094551 0.84 CNR1 (0.49) CNR1PTGS2PTGS1CA12CA1
SCHEMBL8776744 0.84 SQOR (0.46) CNR1PTGS2PTGS1CA1CA2
SCHEMBL8093715 0.82 CNR1 (0.46) CNR1PTGS2PTGS1CA12CA1
SCHEMBL8094547 0.82 PTGS2 (0.60) CNR1PTGS2PTGS1CA12CA1
SCHEMBL8085721 0.82 CNR1 (0.48) CNR1PTGS2PTGS1CA12CA1
SCHEMBL8086461 0.81 CNR1 (0.61) CNR1PTGS2PTGS1CA12CA1
SCHEMBL8094093 0.81 CNR1 (0.46) CNR1PTGS2PTGS1CA12CA1
SCHEMBL8094989 0.81 PTGS2 (0.53) CNR1PTGS2PTGS1CA12CA1
SCHEMBL8093195 0.81 PTGS2 (0.47) CNR1PTGS2PTGS1CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0808304-B1 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2000-12-27 EP disclosed
EP-0808304-A1 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-11-26 EP disclosed
WO-1996024584-A1 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-08-15 WO disclosed